China Pharma Holdings, Inc. CPHI

0.75 0.01 1.35% as of 25 Sep
Market cap
$31.8M
P/E
0.0×
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
P/E ratio
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
P/S ratio
1.25 0.89 0.29 0.58 2.30 1.81 0.96 0.92 0.56 0.70
P/FCF ratio
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 14.16
P/Operating CF
34.16 13.44 (91.05) 8.09 (111.82) 58.60 (473.48) 12.96 7.91 7.39
P/B ratio
0.23 0.52 0.27 1.10 3.68 2.45 1.13 0.38 0.17 0.19
Price to Tangible BV
0.00 3.82 0.48 1.91 3.77 2.51 1.16 0.38 0.17 0.19
EV/Sales
1.97 1.28 0.43 1.22 2.78 2.19 1.24 1.25 1.05 1.11
EV/EBITDA
0.00 0.00 1,657.33 0.00 56.11 235.91 0.00 0.00 0.00 0.00
EV/Operating CF
54.92 (14.23) (4.26) (24.12) (107.21) (563.83) 22.25 8.18 16.47 5.95
EV/FCF
(184.67) (2.47) (1.13) (3.60) (11.21) (8.39) (9.27) (151.42) (11.28) 22.38
Quick Ratio
0.09 0.18 0.32 0.20 0.54 0.14 0.19 0.36 0.57 0.77
Current Ratio
0.32 0.65 0.88 0.47 0.86 0.47 0.56 0.87 1.33 1.69
Net Debt/EBITDA
(0.98) (0.92) 529.33 (0.47) 9.70 41.80 (0.18) (0.57) (0.42) (1.25)
Debt/Assets
6.38% 16.17% 14.83% 13.73% 42.29% 24.82% 19.34% 14.42% 15.38% 12.84%
Debt/Equity
0.09 0.31 0.33 0.57 1.59 0.65 0.47 0.22 0.21 0.17
Asset Turnover
0.18 0.29 0.41 0.40 0.44 0.50 0.32 0.23 0.19 0.18
Operating CF/Net income
(0.05) 0.09 0.23 0.10 0.07 0.01 (0.03) (0.18) (0.04) (0.32)
Capex/Depreciation
(0.09) (0.11) 0.00 (0.15) (0.13) (0.32) (0.05) (0.02) (0.04) (0.06)
Interest Coverage
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
ROE
(20.91%) (62.31%) (52.43%) (77.08%) (48.49%) (33.25%) (104.99%) (29.34%) (37.81%) (13.96%)
ROA
(13.89%) (30.21%) (17.98%) (19.65%) (15.53%) (13.23%) (61.24%) (20.41%) (27.84%) (10.49%)
ROIC
(8.31%) (30.16%) (20.46%) (47.32%) (16.79%) (13.17%) (103.64%) (19.06%) (23.58%) (7.81%)
Return on Tangible Assets
481.51% (151.01%) (49.05%) (124.22%) (28.66%) (30.23%) (174.74%) (59.76%) (72.46%) (28.62%)
Average Days of Receivables
25.60 21.15 34.48 20.30 28.16 17.79 22.79 32.18 67.85 99.02
Research and Development Expense of Revenue
6.78% 6.27% 3.42% 2.29% 3.31% 3.48% 2.10% 1.40% 0.68% 2.35%
Selling, General and Administrative Expense of Revenue
68.22% 51.09% 32.04% 36.56% 32.63% 37.16% 42.49% 41.90% 41.48% 40.48%
Intangible Assets out of Total Assets
0.78 0.45 0.20 0.10 0.01 0.01 0.01 0.01 0.01 0.01
Share Based Compensation of Revenue
0.00% 0.00% 0.00% 0.97% 0.16% 0.00% 0.00% 0.00% 0.00% 0.00%
Graham Net Nets
(1.14) (0.96) (1.49) (1.59) (0.34) (0.40) (0.71) (0.57) (0.62) (0.19)
Graham Number
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Yield
(61.98%) (117.39%) (145.03%) (83.94%) (16.67%) (14.41%) (200.00%) (91.05%) (258.82%) (88.00%)
Free Cash Flow Yield
(0.85%) (58.18%) (130.22%) (58.02%) (10.78%) (14.49%) (13.96%) (0.90%) (16.57%) 7.06%
Revenue per Share
0.97 2.59 20.72 77.11 104.46 124.62 125.27 141.41 151.52 178.56
Operating CF per Share
0.03 (0.23) (2.07) (3.90) (2.71) (0.49) 6.98 21.58 9.65 33.21
Capex per Share
(0.03) (0.17) (0.03) (3.82) (4.75) (9.95) (1.56) (0.59) (1.57) (2.22)
Free Cash Flow per Share
0.00 (0.40) (2.10) (7.72) (7.45) (10.43) 5.42 21.00 8.08 30.99
Cash per Share
0.08 0.37 4.40 19.45 53.63 11.60 14.11 28.45 31.88 43.06
Shareholders Equity per Share
5.30 4.44 22.03 40.82 65.20 91.79 105.94 346.32 493.94 675.56
Interest Debt per Share
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
5.30 4.44 22.03 40.82 65.20 91.79 105.94 346.32 493.94 675.56
Free Cash Flow
0.01 (0.70) (0.71) (0.81) (0.69) (0.91) 0.47 1.83 0.70 2.70
Working Capital
(5.05) (1.75) (0.82) (6.77) (1.42) (6.08) (4.47) (1.30) 3.06 7.12
Capital Expenditures
(0.14) (0.29) (0.01) (0.40) (0.44) (0.87) (0.14) (0.05) (0.14) (0.19)
Net Current Asset Value
(5.91) (3.87) (3.02) (7.53) (7.54) (7.79) (7.42) (6.43) (4.59) (2.09)
EV/EBIT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Capex to Sales
0.03 0.06 0.00 0.05 0.05 0.08 0.01 0.00 0.01 0.01
Net Profit Margin
(76.92%) (104.58%) (43.91%) (49.02%) (35.26%) (26.38%) (189.51%) (87.18%) (145.91%) (58.97%)
Price to Operating Income
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other line items
Depreciation/Fixed assets
0.36 0.55 0.39 0.27 0.25 0.17 0.18 0.17 0.14 0.12
Cash ROIC
(16.93%) (48.98%) (68.50%) (118.32%) (65.85%) (109.46%) (106.34%) (44.39%) (41.22%) (30.34%)
Accounts Receivable Turnover
14.99 9.79 12.60 13.57 15.14 17.94 12.35 6.96 3.96 3.21
Accounts Payable Turnover
7.66 10.94 8.93 10.79 8.60 6.85 7.78 9.41 5.11 4.49
Inventory Turnover
2.20 2.17 2.18 2.74 2.64 2.44 2.18 1.81 1.57 1.46
Average Days of Payables
76.06 12.61 48.37 28.32 36.40 50.56 52.82 37.39 38.77 90.43
Days of Inventory on Hand
138.40 126.97 186.82 125.14 131.18 151.72 138.74 178.17 217.67 216.04
Average Receivables
0.28 0.46 0.56 0.60 0.64 0.61 0.88 1.77 3.34 4.84
Average Payables
0.56 0.60 0.82 0.80 1.08 1.30 1.21 1.10 2.10 2.75
Average Inventory
1.94 3.00 3.34 3.14 3.52 3.65 4.32 5.73 6.86 8.49
Average Assets
22.94 15.68 17.13 20.22 21.88 21.68 33.81 52.67 69.24 87.52
Average Common Equity
15.24 7.60 5.87 5.15 7.01 8.62 19.72 36.64 50.99 65.78

Fold the line items

Columns are period end dates